Edward Yakubovich

4PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 13, 2024
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway.

Jonathan J Hodgins, John Abou-Hamad, Colin Edward O'Dwyer

|Dec 12, 2023
Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis.

Edward Yakubovich, David P Cook, Galaxia M Rodriguez

|Dec 09, 2023
Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.

Galaxia M Rodriguez, Edward Yakubovich, Barbara C Vanderhyden

|Sep 02, 2022
Metformin prevents age-associated ovarian fibrosis by modulating the immune landscape in female mice.

David A Landry, Edward Yakubovich, David P Cook

Pageof 1